These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16008407)

  • 41. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
    Hou L; Zagorski MG
    J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serpin acceleration of amyloid fibril formation: a role for accessory proteins.
    Powers GA; Pham CL; Pearce MC; Howlett GJ; Bottomley SP
    J Mol Biol; 2007 Feb; 366(2):666-76. PubMed ID: 17174330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designed amyloid beta peptide fibril - a tool for high-throughput screening of fibril inhibitors.
    Dolphin GT; Ouberai M; Dumy P; Garcia J
    ChemMedChem; 2007 Nov; 2(11):1613-23. PubMed ID: 17876751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation.
    Lambermon MH; Rappaport RV; McLaurin J
    J Neurochem; 2005 Dec; 95(6):1667-76. PubMed ID: 16300644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibril aggregation inhibitory activity of the beta-sheet breaker peptides: a molecular docking approach.
    Chini MG; Scrima M; D'Ursi AM; Bifulco G
    J Pept Sci; 2009 Mar; 15(3):229-34. PubMed ID: 19090016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adsorption of nonionic surfactants on cellulose surfaces: adsorbed amounts and kinetics.
    Torn LH; Koopal LK; de Keizer A; Lyklema J
    Langmuir; 2005 Aug; 21(17):7768-75. PubMed ID: 16089382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thermodynamics of A beta(1-40) amyloid fibril elongation.
    O'Nuallain B; Shivaprasad S; Kheterpal I; Wetzel R
    Biochemistry; 2005 Sep; 44(38):12709-18. PubMed ID: 16171385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ganglioside G(M1)-mediated amyloid-beta fibrillogenesis and membrane disruption.
    Chi EY; Frey SL; Lee KY
    Biochemistry; 2007 Feb; 46(7):1913-24. PubMed ID: 17256880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stoichiometric inhibition of amyloid beta-protein aggregation with peptides containing alternating alpha,alpha-disubstituted amino acids.
    Etienne MA; Aucoin JP; Fu Y; McCarley RL; Hammer RP
    J Am Chem Soc; 2006 Mar; 128(11):3522-3. PubMed ID: 16536517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42.
    D'Arrigo C; Tabaton M; Perico A
    Biopolymers; 2009 Oct; 91(10):861-73. PubMed ID: 19562755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quaternary structure of a mature amyloid fibril from Alzheimer's Abeta(1-40) peptide.
    Sachse C; Xu C; Wieligmann K; Diekmann S; Grigorieff N; Fändrich M
    J Mol Biol; 2006 Sep; 362(2):347-54. PubMed ID: 16920151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R; Caflisch A
    J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of Abeta conformation on the metal affinity and aggregation mechanism studied by circular dichroism spectroscopy.
    Chen YR; Huang HB; Chyan CL; Shiao MS; Lin TH; Chen YC
    J Biochem; 2006 Apr; 139(4):733-40. PubMed ID: 16672274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of n-alkyl trimethylammonium bromides on folding and stability of alkaline and acid-denatured cytochrome c: a spectroscopic approach.
    Chamani J; Moosavi-Movahedi AA
    J Colloid Interface Sci; 2006 May; 297(2):561-9. PubMed ID: 16338232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
    Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
    Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quenched hydrogen/deuterium exchange NMR characterization of amyloid-beta peptide aggregates formed in the presence of Cu2+ or Zn2+.
    Olofsson A; Lindhagen-Persson M; Vestling M; Sauer-Eriksson AE; Ohman A
    FEBS J; 2009 Aug; 276(15):4051-60. PubMed ID: 19549187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35).
    Han W; Wu YD
    J Am Chem Soc; 2005 Nov; 127(44):15408-16. PubMed ID: 16262404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermodynamics and dynamics of amyloid peptide oligomerization are sequence dependent.
    Lu Y; Derreumaux P; Guo Z; Mousseau N; Wei G
    Proteins; 2009 Jun; 75(4):954-63. PubMed ID: 19089954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-beta protein.
    Kotarek JA; Johnson KC; Moss MA
    Anal Biochem; 2008 Jul; 378(1):15-24. PubMed ID: 18396143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.